BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36719907)

  • 21. Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study.
    Hippisley-Cox J; Coupland CA; Mehta N; Keogh RH; Diaz-Ordaz K; Khunti K; Lyons RA; Kee F; Sheikh A; Rahman S; Valabhji J; Harrison EM; Sellen P; Haq N; Semple MG; Johnson PWM; Hayward A; Nguyen-Van-Tam JS
    BMJ; 2021 Sep; 374():n2244. PubMed ID: 34535466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-titer post-vaccine COVID-19 convalescent plasma for immunocompromised patients during the first omicron surge.
    Tayyar R; Wong LK; Dahlen A; Shu E; Pandey S; Liu AY
    Transpl Infect Dis; 2023 Apr; 25(2):e14055. PubMed ID: 36929619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study.
    Maximiano Sousa F; Roelens M; Fricker B; Thiabaud A; Iten A; Cusini A; Flury D; Buettcher M; Zukol F; Balmelli C; Zimmermann P; Troillet N; Vuichard-Gysin D; Schreiber PW; Bernhard-Stirnemann S; Tschudin-Sutter S; Nussbaumer-Ochsner Y; Sommerstein R; Gaudenz R; Marschall J; Senn L; Gardiol C; Keiser O; Schüpbach G; Wymann M; Vidondo B; Ch-Sur Study Group
    Swiss Med Wkly; 2021 Jul; 151():w20547. PubMed ID: 34324698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethnicity and outcomes in patients hospitalised with COVID-19 infection in East London: an observational cohort study.
    Apea VJ; Wan YI; Dhairyawan R; Puthucheary ZA; Pearse RM; Orkin CM; Prowle JR
    BMJ Open; 2021 Jan; 11(1):e042140. PubMed ID: 33455936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study.
    Agrawal U; Katikireddi SV; McCowan C; Mulholland RH; Azcoaga-Lorenzo A; Amele S; Fagbamigbe AF; Vasileiou E; Grange Z; Shi T; Kerr S; Moore E; Murray JLK; Shah SA; Ritchie L; O'Reilly D; Stock SJ; Beggs J; Chuter A; Torabi F; Akbari A; Bedston S; McMenamin J; Wood R; Tang RSM; de Lusignan S; Hobbs FDR; Woolhouse M; Simpson CR; Robertson C; Sheikh A
    Lancet Respir Med; 2021 Dec; 9(12):1439-1449. PubMed ID: 34599903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
    Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
    Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study.
    Gupta RK; Harrison EM; Ho A; Docherty AB; Knight SR; van Smeden M; Abubakar I; Lipman M; Quartagno M; Pius R; Buchan I; Carson G; Drake TM; Dunning J; Fairfield CJ; Gamble C; Green CA; Halpin S; Hardwick HE; Holden KA; Horby PW; Jackson C; Mclean KA; Merson L; Nguyen-Van-Tam JS; Norman L; Olliaro PL; Pritchard MG; Russell CD; Scott-Brown J; Shaw CA; Sheikh A; Solomon T; Sudlow C; Swann OV; Turtle L; Openshaw PJM; Baillie JK; Semple MG; Noursadeghi M;
    Lancet Respir Med; 2021 Apr; 9(4):349-359. PubMed ID: 33444539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID-19: Analysis of the ISARIC CCP-UK Cohort.
    Yates T; Zaccardi F; Islam N; Razieh C; Gillies CL; Lawson CA; Chudasama Y; Rowlands A; Davies MJ; Docherty AB; Openshaw PJM; Baillie JK; Semple MG; ; Khunti K
    Obesity (Silver Spring); 2021 Jul; 29(7):1223-1230. PubMed ID: 33755331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.
    Embi PJ; Levy ME; Naleway AL; Patel P; Gaglani M; Natarajan K; Dascomb K; Ong TC; Klein NP; Liao IC; Grannis SJ; Han J; Stenehjem E; Dunne MM; Lewis N; Irving SA; Rao S; McEvoy C; Bozio CH; Murthy K; Dixon BE; Grisel N; Yang DH; Goddard K; Kharbanda AB; Reynolds S; Raiyani C; Fadel WF; Arndorfer J; Rowley EA; Fireman B; Ferdinands J; Valvi NR; Ball SW; Zerbo O; Griggs EP; Mitchell PK; Porter RM; Kiduko SA; Blanton L; Zhuang Y; Steffens A; Reese SE; Olson N; Williams J; Dickerson M; McMorrow M; Schrag SJ; Verani JR; Fry AM; Azziz-Baumgartner E; Barron MA; Thompson MG; DeSilva MB
    MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(44):1553-1559. PubMed ID: 34735426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.
    Pinato DJ; Scotti L; Gennari A; Colomba-Blameble E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Aguilar-Company J; Bower M; Galazi M; Salazar R; Bertuzzi A; Brunet J; Mesia R; Sita-Lumsden A; Colomba J; Pommeret F; Seguí E; Biello F; Generali D; Grisanti S; Rizzo G; Libertini M; Moss C; Evans JS; Russell B; Wuerstlein R; Vincenzi B; Bertulli R; Ottaviani D; Liñan R; Marrari A; Carmona-García MC; Sng CCT; Tondini C; Mirallas O; Tovazzi V; Fotia V; Cruz CA; Saoudi-Gonzalez N; Felip E; R Lloveras A; Lee AJX; Newsom-Davis T; Sharkey R; Chung C; García-Illescas D; Reyes R; Sophia Wong YN; Ferrante D; Marco-Hernández J; Ruiz-Camps I; Gaidano G; Patriarca A; Sureda A; Martinez-Vila C; Sanchez de Torre A; Rimassa L; Chiudinelli L; Franchi M; Krengli M; Santoro A; Prat A; Tabernero J; V Hemelrijck M; Diamantis N; Cortellini A;
    Eur J Cancer; 2021 Jun; 150():190-202. PubMed ID: 33932726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relevance of prediction scores derived from the SARS-CoV-2 first wave, in the evolving UK COVID-19 second wave, for safe early discharge and mortality: a PREDICT COVID-19 UK prospective observational cohort study.
    Ghani H; Navarra A; Pyae PK; Mitchell H; Evans W; Cama R; Shaw M; Critchlow B; Vaghela T; Schechter M; Nordin N; Barlow A; Vancheeswaran R
    BMJ Open; 2022 Dec; 12(12):e054469. PubMed ID: 36600417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
    Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
    Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation of 22445 patients attending UK emergency departments with suspected COVID-19 infection: Observational cohort study.
    Goodacre S; Thomas B; Lee E; Sutton L; Loban A; Waterhouse S; Simmonds R; Biggs K; Marincowitz C; Schutter J; Connelly S; Sheldon E; Hall J; Young E; Bentley A; Challen K; Fitzsimmons C; Harris T; Lecky F; Lee A; Maconochie I; Walter D
    PLoS One; 2020; 15(11):e0240206. PubMed ID: 33237907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19-related outcomes in immunocompromised patients: A nationwide study in Korea.
    Baek MS; Lee MT; Kim WY; Choi JC; Jung SY
    PLoS One; 2021; 16(10):e0257641. PubMed ID: 34597325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study.
    Reyes LF; Murthy S; Garcia-Gallo E; Merson L; Ibáñez-Prada ED; Rello J; Fuentes YV; Martin-Loeches I; Bozza F; Duque S; Taccone FS; Fowler RA; Kartsonaki C; Gonçalves BP; Citarella BW; Aryal D; Burhan E; Cummings MJ; Delmas C; Diaz R; Figueiredo-Mello C; Hashmi M; Panda PK; Jiménez MP; Rincon DFB; Thomson D; Nichol A; Marshall JC; Olliaro PL;
    Crit Care; 2022 Sep; 26(1):276. PubMed ID: 36100904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.